{"id":"https://openalex.org/W7214775425","doi":"https://doi.org/10.31351/vol35iss3pp151-158","title":"Development and validation of a specific method for the detection and quantification of Bortezomib in the prepared Bortezomib bovine serum albumin nanoparticles","display_name":"Development and validation of a specific method for the detection and quantification of Bortezomib in the prepared Bortezomib bovine serum albumin nanoparticles","publication_year":2026,"publication_date":"2026-09-28","ids":{"openalex":"https://openalex.org/W7214775425","doi":"https://doi.org/10.31351/vol35iss3pp151-158"},"language":"en","primary_location":{"id":"doi:10.31351/vol35iss3pp151-158","doi":"https://doi.org/10.31351/vol35iss3pp151-158","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol35iss3pp151-158","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/4393/1645","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/4393/1645","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019516602","display_name":"Areej Wahhab Alhagiesa","orcid":"https://orcid.org/0009-0006-2675-8364","observed_orcids":["https://orcid.org/0009-0006-2675-8364"]},"institutions":[{"id":"https://openalex.org/I47229656","display_name":"University of Kufa","ror":"https://ror.org/02dwrdh81","country_code":"IQ","type":"education","lineage":["https://openalex.org/I47229656"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Areej W. Alhagiesa","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, University of Kufa, Najaf City, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, University of Kufa, Najaf City, Iraq","institution_ids":["https://openalex.org/I47229656"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022224502","display_name":"Mowafaq Mohammed Ghareeb","orcid":"https://orcid.org/0000-0002-9968-7396","observed_orcids":["https://orcid.org/0000-0002-9968-7396"]},"institutions":[{"id":"https://openalex.org/I135120706","display_name":"University of Baghdad","ror":"https://ror.org/007f1da21","country_code":"IQ","type":"education","lineage":["https://openalex.org/I135120706"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Mowafaq M. Ghareeb","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad City, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad City, Iraq","institution_ids":["https://openalex.org/I135120706"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":250000,"currency":"IQD","value_usd":null},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"3","first_page":"151","last_page":"158"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/bovine-serum-albumin-nanoparticles","display_name":"bovine serum albumin nanoparticles","score":0.9319999814033508},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7590000033378601},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.7900000214576721},{"id":"https://openalex.org/keywords/hplc-method-development","display_name":"HPLC method development","score":0.7699999809265137},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.7730000019073486},{"id":"https://openalex.org/keywords/drug-quantification","display_name":"pharmaceutical analysis","score":0.8349999785423279},{"id":"https://openalex.org/keywords/drug-detection","display_name":"drug detection","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.9006999731063843},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6381000280380249},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6345000267028809},{"id":"https://openalex.org/C86807702","wikidata":"https://www.wikidata.org/wiki/Q2620381","display_name":"Bovine serum albumin","level":2,"score":0.491100013256073},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.4909000098705292},{"id":"https://openalex.org/C77170095","wikidata":"https://www.wikidata.org/wiki/Q1753188","display_name":"Linearity","level":2,"score":0.41440001130104065},{"id":"https://openalex.org/C119128265","wikidata":"https://www.wikidata.org/wiki/Q900165","display_name":"Detection limit","level":2,"score":0.3481000065803528},{"id":"https://openalex.org/C3020018676","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Retention time","level":2,"score":0.3479999899864197},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.32749998569488525},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.3140999972820282},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.29670000076293945},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.2928999960422516},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2800999879837036},{"id":"https://openalex.org/C202799725","wikidata":"https://www.wikidata.org/wiki/Q272035","display_name":"Accuracy and precision","level":2,"score":0.27970001101493835},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.2689000070095062},{"id":"https://openalex.org/C95986675","wikidata":"https://www.wikidata.org/wiki/Q185168","display_name":"Quantitative analysis (chemistry)","level":2,"score":0.26499998569488525},{"id":"https://openalex.org/C10349863","wikidata":"https://www.wikidata.org/wiki/Q6553497","display_name":"Linear range","level":3,"score":0.26190000772476196},{"id":"https://openalex.org/C2776179129","wikidata":"https://www.wikidata.org/wiki/Q7998640","display_name":"Wide dynamic range","level":2,"score":0.2540000081062317}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.31351/vol35iss3pp151-158","doi":"https://doi.org/10.31351/vol35iss3pp151-158","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol35iss3pp151-158","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/4393/1645","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:c02275b5436b4c86a887419a25df0eec","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c02275b5436b4c86a887419a25df0eec","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences, Vol 35, Iss 3 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.31351/vol35iss3pp151-158","doi":"https://doi.org/10.31351/vol35iss3pp151-158","is_oa":true,"landing_page_url":"https://doi.org/10.31351/vol35iss3pp151-158","pdf_url":"https://bijps.uobaghdad.edu.iq/index.php/bijps/article/download/4393/1645","source":{"id":"https://openalex.org/S2764399167","display_name":"Iraqi Journal of Pharmaceutical Sciences","issn_l":"1683-3597","issn":["1683-3597","2521-3512"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310319170","host_organization_name":"University of Baghdad","host_organization_lineage":["https://openalex.org/P4310319170"],"host_organization_lineage_names":["University of Baghdad"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iraqi Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.504800021648407,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310603","display_name":"University of Baghdad","ror":"https://ror.org/007f1da21"},{"id":"https://openalex.org/F4320317244","display_name":"University of Kufa","ror":"https://ror.org/02dwrdh81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214775425.pdf","grobid_xml":"https://content.openalex.org/works/W7214775425.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4381892202","https://openalex.org/W2274389158","https://openalex.org/W2187485281","https://openalex.org/W1942540093","https://openalex.org/W7219389141","https://openalex.org/W2349550833","https://openalex.org/W2911341136","https://openalex.org/W4409512420","https://openalex.org/W2581413192","https://openalex.org/W7171617008"],"abstract_inverted_index":{"New,":[0],"simple":[1],"and":[2,27,55,84,109,121,137,145,155,184],"precise":[3,83],"analytical":[4],"method":[5,24,172],"for":[6,64,128,153],"the":[7,95,105,112,129,158,170],"detection":[8,57,154],"of":[9,44,52,97,114,157],"Bortezomib":[10,130],"which":[11,92],"it":[12],"is":[13,25,67,78,163,173],"a":[14,102,118,125,150],"selecti":[15],"proteosome":[16],"inhibitor":[17],"acting":[18],"as":[19],"powerful":[20],"anticancer":[21],"drug.":[22],"This":[23],"developed":[26],"validated":[28,174],"using":[29],"reverse":[30],"phase":[31,42],"High":[32],"performance":[33],"liquid":[34],"chromatography":[35],"(HPLC)":[36],"device":[37],"with(":[38],"C18,4.6\u00d7250mm":[39],")column,":[40],"mobile":[41],"composed":[43],"methanol:":[45],"water":[46],"(70:30)":[47],",":[48],"isocratic":[49],"flow":[50],"rate":[51],"1":[53],"ml/min":[54],"UV":[56],"at":[58],"270":[59],"nm.":[60],"The":[61,160],"retention":[62],"time":[63],"this":[65,75],"drug":[66],"found":[68],"to":[69,81,142,165,176],"be":[70,82,143,166],"6.77":[71],"minute":[72],"by":[73],"utilizing":[74],"method.":[76],"It":[77,99],"also":[79,100,140,162],"proved":[80],"specific":[85],"with":[86,94,117],"an":[87],"RSD%":[88],"less":[89],"than":[90],"2%":[91],"complies":[93],"requirement":[96],"ICH.":[98],"shows":[101],"linearity":[103],"in":[104,111,132],"both":[106],"responses":[107],"(area":[108],"height)":[110],"range":[113,127],"10-100":[115],"\u00b5g/ml":[116,147],"R2":[119],"0.997":[120],"0.998":[122],"respectively,":[123,148],"indicating":[124],"wide":[126],"measurement":[131],"different":[133],"pharmaceutical":[134],"formulations.":[135],"LOD":[136],"LOQ":[138],"were":[139],"calculated":[141],"3.2":[144],"9.6":[146],"showing":[149],"low":[151],"level":[152],"quantification":[156],"item.":[159],"accuracy":[161,183],"determined":[164],"99.83%\u00b10.77.":[167],"In":[168],"conclusion":[169],"suggested":[171],"according":[175],"ICH":[177],"guidelines":[178],"regarding":[179],"precision,":[180],"specificity,":[181],"linearity,":[182],"robustness.":[185]},"counts_by_year":[],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2026-09-30T00:00:00"}